Syntara Ltd logo

Syntara Ltd

0
ASX:SNT (Australia)  
A$ 0.04 (-4.65%) Nov 8
At Loss
P/B:
10.75
Market Cap:
A$ 56.30M ($ 37.05M)
Enterprise V:
A$ 53.01M ($ 34.89M)
Volume:
1.86M
Avg Vol (2M):
2.05M
Trade In:
Volume:
1.86M
At Loss
Avg Vol (2M):
2.05M

Business Description

Description
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 15.11
Equity-to-Asset 0.45
Debt-to-Equity 0.05
Debt-to-EBITDA -0.02
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -21.88
Distress
Grey
Safe
Beneish M-Score -5.43
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.43
9-Day RSI 42.22
14-Day RSI 46.27
6-1 Month Momentum % 133.33
12-1 Month Momentum % 40

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.79
Quick Ratio 1.79
Cash Ratio 0.65
Days Inventory 268.29
Days Sales Outstanding 109.18
Days Payable 148.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.1
Shareholder Yield % -12.72

Financials

ASX:SNT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Syntara Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.016
Beta 1.15
Volatility % 77.57
14-Day RSI 46.27
14-Day ATR (A$) 0.003809
20-Day SMA (A$) 0.0449
12-1 Month Momentum % 40
52-Week Range (A$) 0.014 - 0.058
Shares Outstanding (Mil) 1,373.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syntara Ltd Filings

Filing Date Document Date Form
No Filing Data

Syntara Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Syntara Ltd Frequently Asked Questions

What is Syntara Ltd(ASX:SNT)'s stock price today?
The current price of ASX:SNT is A$0.04. The 52 week high of ASX:SNT is A$0.06 and 52 week low is A$0.01.
When is next earnings date of Syntara Ltd(ASX:SNT)?
The next earnings date of Syntara Ltd(ASX:SNT) is .
Does Syntara Ltd(ASX:SNT) pay dividends? If so, how much?
Syntara Ltd(ASX:SNT) does not pay dividend.

Press Release

Subject Date
No Press Release